Loading
Latest filing published 16 Jun 2026 for Adial Pharmaceuticals, INC.. Read the official filing
No signal scores available.
Matt Davidson discloses dealings in Adial Pharmaceuticals, Inc. to SEC (Form 4). Between 11 June 2026 and 12 June 2026, the trades on record add up to 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 16 June 2026 with a share grant in Adial Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations